U.S. Water Utilities Stock News

IDEX (IEX) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months, prompting a closer look at its current valuation setup. See our latest analysis for IDEX. At around $197.90, IDEX’s recent 1 day and 7 day share price declines of 2.67% and 5.52% sit against a 90 day share price return of 11.47% and year to date share price return of 10.52%. Longer multi year total shareholder returns have been more muted, which...

GlobalFoundries (NasdaqGS:GFS) announced a multi billion dollar manufacturing partnership with Renesas Electronics. The agreement focuses on supplying automotive grade chips, particularly microcontrollers used across vehicles. Production is set to begin in the US, with plans for future capacity expansion in other regions. The partnership is framed as a way to support supply chain security for critical automotive semiconductors. For GlobalFoundries, this deal sits at the intersection of its...

In late February, Ares Management filed an omnibus shelf registration covering Class A common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, and units, while also participating in a multi‑billion‑dollar unitranche financing backing Thoma Bravo’s acquisition and merger of WWEX Group and Auctane. These developments came as Ares faced increased scrutiny over private credit risks and an earnings miss, highlighting the tension between its expanding...

How Cigna Group’s Recent Performance Sets Up the Valuation Debate Cigna Group (CI) has drawn investor attention after recent share performance that includes a 3.4% one day decline and a 6.3% drop over the past week, sharpening focus on its current valuation and fundamentals. See our latest analysis for Cigna Group. The recent 1 day share price decline and weak 7 day share price return compare with a year to date share price decline of 2.7% and a 1 year total shareholder return decline of...

Ionis Pharmaceuticals (IONS) is back in focus after the US FDA accepted a Priority Review for its supplemental New Drug Application for olezarsen in severe hypertriglyceridemia, placing a key RNA medicine under a tighter regulatory timeline. See our latest analysis for Ionis Pharmaceuticals. Despite the latest FDA Priority Review, Ionis Pharmaceuticals' recent share price momentum has cooled, with a 30 day share price return of 12.88% and a year to date share price return decline of 7.07%,...

What Symbotic’s latest quarter means for investors Symbotic (SYM) reported a fiscal Q1 that featured revenue near US$630 million and margin expansion as more warehouse automation sites moved into steady operations, drawing fresh attention to the stock. See our latest analysis for Symbotic. Despite a stronger fiscal Q1 narrative, Symbotic’s recent share price has been under pressure, with a 1-day share price return of an 8.63% decline and a year-to-date share price return of a 25.07% decline...

With no single headline driving Steel Dynamics (STLD) today, investors are instead weighing its recent performance, including a past 3 months return near 10% and a 1 year total return around 47%. See our latest analysis for Steel Dynamics. At a share price of US$181.61, Steel Dynamics has recently seen a 1 month share price return of about a 9% decline, even though its 1 year total shareholder return is around 47%. This suggests that shorter term momentum looks softer than the longer term...

If you are asking yourself whether Ardelyx at around US$6.19 is attractively priced or not, this article is going to walk through what the current market price might be implying about its value. The share price has seen mixed returns, including a 5.5% decline over the last week and a 16.1% decline over the last month, alongside a 16.8% return over the past year and 73.9% over three years. Year to date performance is around 0.7%, and the 5 year return reflects an 11.2% decline. Recent trading...

Biogen (NasdaqGS:BIIB) and Stoke Therapeutics reported promising clinical results for zorevunersen in Dravet syndrome, with data highlighting durable seizure reductions and cognitive benefits. The zorevunersen findings were published in The New England Journal of Medicine, supporting its potential as a disease modifying therapy for this rare, severe epilepsy. Biogen released new high dose SPINRAZA data for spinal muscular atrophy, including long term safety and efficacy updates. The company...

If you are wondering whether MarketAxess Holdings at around US$186 still reflects its underlying value, this article walks through the key numbers that matter. The stock has had a mixed run, with a 14.6% return over the last 30 days and a 4.2% gain year to date, set against a 9.5% decline over 1 year and deeper falls of 44.1% over 3 years and 62.0% over 5 years. These moves have kept MarketAxess on the radar for investors who follow how electronic bond trading platforms are priced and used,...

If you are wondering whether GDS Holdings is priced attractively today or if the recent share moves have already priced in the story, this article walks through what the numbers are really saying about its valuation. The stock last closed at US$40.87, with a 12.4% return over the past year, a 6.6% gain year to date, and longer term results that include a very large 3 year return alongside a 55.2% decline over 5 years, which can change how investors view both its potential and its...

USA Rare Earth (NasdaqGM:USAR) is acquiring all outstanding shares of Texas Mineral Resources. The deal consolidates 100% ownership and control of the Round Top Project in Texas. Round Top is described as one of the largest rare earth deposits in North America. Completion of the transaction makes USA Rare Earth the sole operator and economic beneficiary of the project. For you as an investor, this move places a key U.S. rare earth asset fully under NasdaqGM:USAR, aligning ownership,...

Willis Lease Finance (WLFC) just paired two expansion themed moves by naming aviation finance veteran Marilyn Gan as Head of Origination, Asia Pacific and completing a six aircraft Dash 8 400 purchase and leaseback with Porter Airlines. See our latest analysis for Willis Lease Finance. Those moves come after a sharp pullback, with a 7 day share price return of 12.32% and a 1 day dip of 3.82%. Over a 90 day period the share price return is 36.31%, and the 3 year total shareholder return is...

Regency Centers overview and recent share performance Regency Centers (REG) has attracted fresh attention among income focused investors. The real estate investment trust operates grocery anchored shopping centers, is included in the S&P 500, and recently traded at a share price of $78.66. Over the past month the stock shows a 5.9% return, with around 14.5% over the past 3 months and about 15.7% year to date, while the 1 year total return stands near 10.7%. See our latest analysis for Regency...

Paramount Skydance (NasdaqGS:PSKY) has secured board approval from Warner Bros. Discovery for a "Superior Proposal" acquisition. The deal combines Paramount Skydance with Warner Bros. Discovery’s film, TV, and streaming assets in what is described as the largest media industry transaction of the decade. Credit rating agencies have issued downgrades and reviews tied to the higher leverage expected once the transaction closes. U.S. telecom regulators have commented on the merger, underscoring...

Global Ship Lease, Inc. reported past fourth-quarter 2025 revenue of US$190.95 million and net income of US$102.61 million, with full-year 2025 revenue of US$766.45 million and net income of US$416.46 million, all higher than the prior year. Alongside these results, the company renewed and upgraded its fleet, locked in US$2.24 billion of contracted revenue with high charter coverage, reduced debt, and raised its dividend, increasing earnings visibility despite geopolitical uncertainty in key...

In February 2026, ONEOK, Inc. reported past fourth-quarter and full-year 2025 results showing higher revenue and net income, issued 2026 earnings and volume guidance, and updated progress on its share repurchase program. The company paired these results with a 4% dividend increase, US$3.10 billions of long-term debt reduction, and sizable acquisition synergies, highlighting a focus on balance sheet strength and shareholder returns. We’ll now examine how ONEOK’s higher dividend and improved...

Recent performance snapshot Adecoagro (AGRO) has caught investor attention after a recent share price move, with the stock closing at US$10.16 and showing positive returns over the past week, month and past 3 months. Alongside this price action, the company reports annual revenue of US$1,386.018m and net income of US$23.403m. This provides a basic sense of its current scale and profitability before looking deeper into the business mix. See our latest analysis for Adecoagro. The recent 4.74% 1...

Dynex Capital (NYSE:DX) announced a Chief Financial Officer transition, with Michael Sartori appointed as CFO. Sartori succeeds Robert Colligan, who is departing from the role. The company stated that the transition is not related to its financial reporting or internal controls. For shareholders of Dynex Capital, a mortgage REIT focused on fixed income investments, a CFO change is a meaningful development because it touches funding decisions, balance sheet structure, and risk management...

If you are wondering whether Elanco Animal Health's current share price lines up with its underlying worth, this article will walk through the key numbers that matter for valuation. The stock last closed at US$23.36, with returns of 3.7% year to date and 109.7% over the past year, which may have changed how investors think about both its growth potential and risk. Recent coverage around Elanco has focused on its position in animal health and investor interest following its share price moves,...

AppFolio (NasdaqGM:APPF) reports accelerating revenue growth tied to wider adoption of paid services and fresh income streams. Management highlights stronger free cash flow margins alongside this revenue performance. The company outlines a financial outlook that includes expectations for continued topline and margin expansion into 2026. New direct resident-facing offerings are emerging as a meaningful contributor to the overall business model. AppFolio, which provides software and services...

Earnings beat and leadership change put Provident Financial Services (PFS) in focus Provident Financial Services (PFS) recently reported quarterly results that surpassed analyst expectations, a material earnings event that put fresh attention on the bank holding company and its current valuation. The company also announced the upcoming resignation of Valerie O. Murray, President of Beacon Trust Company and Chief Wealth Management Officer, and indicated that her departure is unrelated to...

Why Corteva is on investors’ radar today Corteva (CTVA) is drawing fresh attention after recent share price moves, including a small gain over the past day and a negative return over the past week. This is prompting investors to reassess the agriculture company’s fundamentals. See our latest analysis for Corteva. Zooming out, Corteva’s recent 1-day share price gain and 7-day share price pullback sit against a stronger backdrop, with a 90-day share price return of 16.61% and a 1-year total...

United Therapeutics (NasdaqGS:UTHR) reported highly positive Phase 3 ADVANCE OUTCOMES trial results for ralinepag in pulmonary arterial hypertension. The data showed strong efficacy and safety outcomes in patients enrolled in the study. The company plans to submit a New Drug Application for ralinepag to the US FDA later this year. United Therapeutics focuses on therapies for pulmonary arterial hypertension, a rare and serious cardiopulmonary condition with a significant unmet medical need...